Eton Pharmaceuticals, Inc. · NASDAQ:ETON
BlackRock, Inc. reported a 5.70% stake in Eton Pharmaceuticals, Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Jul 17, 2025
BlackRock, Inc. reported a 5.70% stake in Eton Pharmaceuticals, Inc., 1,530,357 shares, as a passive investor on Jun 30, 2025. Filed Jul 17, 2025 (Schedule 13G).
- Stake
- 5.70%
- Shares
- 1,530,357
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.70% | 1,530,357 |
Source
Related
- Eton Pharmaceuticals, Inc.
- BlackRock, Inc.
- Eton Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Krempa David · Oct 6, 2026
- Form 4/A · Maier Paul V · Aug 31, 2026
- Form 4 · Krempa David · Aug 24, 2026
- Form 4 · Brynjelsen Sean · Aug 20, 2026
- Form 4/A · Opaleye Management Inc. · Jul 17, 2026